Blue Water Acquisition Corp. III is a SPAC — a blank check company with no operations, products, or customers. Blue Water raised $253M in its IPO in June 2025, and those proceeds sit in a trust account invested in U.S. treasuries or money market funds while management searches for an acquisition target. Blue Water has stated an intent to focus on biotechnology, healthcare, and technology companies, but is not required to limit itself to any particular industry. Blue Water has 24 months from its IPO to complete a deal; if it fails, the trust is liquidated and public shareholders receive roughly $10.00 per share back. In November 2025, the original sponsor sold its founder shares and private placement units to a new sponsor, Yorkville BW Acquisition Sponsor, which replaced the entire management team and board. The new sponsor is affiliated with other SPACs, including Texas Ventures Acquisition III Corp. and Yorkville Acquisition Corp. The sponsor received 6,325,000 founder shares for a nominal $25,000 — effectively free equity that converts into Class A shares upon deal completion, which is the sponsor's primary financial incentive. Public investors hold a relatively low-risk position: they can redeem at approximately $10.00 per share if they dislike any announced deal. If a deal closes, Blue Water can structure it using equity, debt, or PIPE financing, which can dilute existing public shareholders.